Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations (Unaudited)

v2.4.0.6
Consolidated Statements of Operations (Unaudited) (USD $)
3 Months Ended 9 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Sep. 30, 2012
Sep. 30, 2011
Revenue:        
Product revenues $ 120,000 $ 2,000 $ 123,000 $ 23,000
License revenues 0 0 0 0
TOTAL REVENUE 120,000 2,000 123,000 23,000
Cost of Product Revenue 32,000 8,000 33,000 48,000
Gross profit (loss) 88,000 (6,000) 90,000 (25,000)
Operating Expenses:        
Research and development 0 0 0 49,000
Selling, general and administrative 1,438,000 535,000 2,865,000 2,806,000
Total operating expenses 1,438,000 535,000 2,865,000 2,855,000
Loss from Operations (1,350,000) (541,000) (2,775,000) (2,880,000)
Change in value of warrant and derivative liabilities 0 681,000 (358,000) 783,000
Interest expense/income (65,000) (117,000) (1,305,000) (465,000)
Total Other Income (Expense) (65,000) 564,000 (1,663,000) 318,000
Loss before minority interest and provision for income taxes (1,415,000) 23,000 (4,438,000) 0
Minority interest in subsidiary 15,000 0 28,000 0
Income (loss) before provision for income taxes (1,400,000) 23,000 (4,410,000) (2,562,000)
Provision for income taxes 0 0 0 0
Net gain (loss) $ (1,400,000) $ 23,000 $ (4,410,000) $ (2,562,000)
Loss Per Share - basic and diluted $ 0.00 $ 0.00 $ (0.01) $ (0.01)
Weighted Average Shares Outstanding - basic and diluted 397,553,268 213,511,550 336,824,712 183,038,141